No abstract

No abstract

A high recombination rate and low charge collection are the main limiting factors of copper oxides (cupric and cuprous oxide) for the photocatalytic degradation of organic pollutants. In this paper, a high performance copper oxide photocatalyst was developed by integrating cupric oxide (CuO) and cuprous oxide (Cu2O) thin films, which showed superior performance for the photocatalytic degradation of methylene blue (MB) compared to the control CuO and Cu2O photocatalyst. Our results show that a heterojunction photocatalyst of CuO–Cu2O thin films could significantly increase the charge collection, reduce the recombination rate, and improve the photocatalytic activity.

The purpose of this work was to develop a type of tissue-engineering scaffold or drug-delivery carrier with the capability of encapsulation and controlled release of dual drugs. In this study, Rhodamine B and bovine serum albumin (BSA) were successfully incorporated into nanofibers by means of blending or coaxial electrospinning. The morphology of composite nanofibers was studied by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The composite nanofibrous mats made from coaxial electrospinning were characterized by X-ray diffraction. In vitro dual-drug release behaviors from composite nanofibrous mats were investigated. From the drug-release profiles, it shows that the location where the drug or protein is put into (into the core or shell of the nanofibers) can affect the drug-release profile in the coaxially electrospun fibers. The results imply that the drug- and/or protein-release profile in composite fibrous mats made from electrospinning can be controlled by altering the coaxial electrospinning process and has significant implications for a wide range of applications such as tissue regeneration, combined therapies or even cancer treatments.